Influenza and Tdap Vaccination Coverage Among Pregnant Women - United States, April 2020.
Influenza and Tdap Vaccination Coverage Among Pregnant Women - United States, April 2020.
MMWR Morb Mortal Wkly Rep. 2020 Oct 02;69(39):1391-1397
Authors: Razzaghi H, Kahn KE, Black CL, Lindley MC, Jatlaoui TC, Fiebelkorn AP, Havers FP, D'Angelo DV, Cheung A, Ruther NA, Williams WW
Abstract
Vaccination of pregnant women with influenza vaccine and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) can decrease the risk for influenza and pertussis among pregnant women and their infants. The Advisory Committee on Immunization Practices (ACIP) recommends that all women who are or might be pregnant during the influenza season receive influenza vaccine, which can be administered at any time during pregnancy (1). ACIP also recommends that women receive Tdap during each pregnancy, preferably during the early part of gestational weeks 27-36 (2,3). Despite these recommendations, vaccination coverage among pregnant women has been found to be suboptimal with racial/ethnic disparities persisting (4-6). To assess influenza and Tdap vaccination coverage among women pregnant during the 2019-20 influenza season, CDC analyzed data from an Internet panel survey conducted during April 2020. Among 1,841 survey respondents who were pregnant anytime during October 2019-January 2020, 61.2% reported receiving influenza vaccine before or during their pregnancy, an increase of 7.5 percentage points compared with the rate during t...
Source: MMWR Morb Mortal Wkl... - Category: Epidemiology Authors: Razzaghi H, Kahn KE, Black CL, Lindley MC, Jatlaoui TC, Fiebelkorn AP, Havers FP, D'Angelo DV, Cheung A, Ruther NA, Williams WW Tags: MMWR Morb Mortal Wkly Rep Source Type: research